Related Experiment Video
Updated: Dec 30, 2025

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
hsa_circ0021347 as a Potential Target Regulated by B7-H3 in Modulating the Malignant Characteristics of Osteosarcoma
Ling Wang1,2, Guo-Chuan Zhang2, Fu-Biao Kang3
1Department of Orthopedics, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Abstract:
In our previous study, we showed that B7-H3 played crucial roles in osteosarcoma (OS) development and might serve as a negative regulator of in osteoimmunology and help tumor cells escape immune surveillance. However, little is known about B7-H3 deficiency and its corresponding circRNA alteration or their relationship with osteosarcoma progression. Therefore, we established stable silencing of B7-H3 in OS cells and validated our results with western blotting and real-time PCR detection. Then, we performed a circRNA array to analyze the differential expression of circRNAs between the control and B7-H3 knockdown cells. The association between target circRNA expression and the clinicopathological features of patients with OS was further analyzed. As a result, hsa_circ0021347 was selected and validated to be significantly downregulated in OS tissues and cell lines and showed a strong negative relationship with B7-H3 expression in OS. In addition, clinicopathological features showed that hsa_circ0021347 in OS tissues was negatively associated with Enneking stage and positively associated with patients' survival. Finally, Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and PANTHER pathway analyses were performed to predict a network of hsa_circ0021347/miRNAs interactions to help us develop potential biomarkers for clinical diagnosis and design therapeutic strategies for OS.
Insights
This study reveals that hsa_circ0021347 is downregulated in osteosarcoma (OS) and linked to better patient survival. Its expression is negatively correlated with B7-H3, suggesting a role in OS progression.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- B7-H3 is implicated in osteosarcoma (OS) development and immune evasion.
- The role of B7-H3 deficiency and associated circRNA alterations in OS progression remains unclear.
Purpose of the Study:
- Investigate the impact of B7-H3 silencing on circRNA expression in OS.
- Identify and validate circRNAs associated with OS progression and B7-H3 expression.
- Explore the clinical significance and potential mechanisms of identified circRNAs in OS.
Main Methods:
- Stable B7-H3 silencing in OS cells.
- Validation using western blotting and real-time PCR.
- CircRNA array analysis for differential expression.
- Correlation analysis with clinicopathological features.
- Bioinformatic pathway analyses (GO, KEGG, PANTHER).
Main Results:
- hsa_circ0021347 was significantly downregulated in OS tissues and cell lines.
- hsa_circ0021347 expression showed a negative correlation with B7-H3 levels in OS.
- hsa_circ0021347 downregulation was associated with advanced Enneking stage and poorer patient survival.
- Predicted miRNA interaction network for hsa_circ0021347.
Conclusions:
- hsa_circ0021347 may function as a tumor suppressor in osteosarcoma.
- hsa_circ0021347 is a potential diagnostic and prognostic biomarker for OS.
- Understanding the hsa_circ0021347/miRNA network could inform novel therapeutic strategies for OS.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
Regulation of Hematopoietic Stem Cells
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway

